| Announce Date | 01/07/2026 |
| EPS Normalized Actual | $2.13 (Beat by $0.38) |
| EPS GAAP Actual | $2.13 (Beat by $0.38) |
| Revenue Actual | $0.769498B |
| Revenue Surprise | Beat by $769.498M |
| Announce Date | 02/28/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.03 |
| EPS GAAP Estimate | $3.03 |
| Revenue Estimate | $0.705775B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2028 | 7.76 | 10.63 | 7.1486 | 8.23044 | 1 |
| May 2028 | 6.67 | 12.37 | 6.23 | 7.11 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 2.14 | 0.32 | 0.769498B | -24.06% | 232.17M |
| FQ3 2025 (Aug 2025) | 4.13 | 4.13 | 0.922602B | 14.82% | 922.6M |
| FQ2 2025 (May 2025) | 7.05 | 7.05 | 1.10366B | 41.94% | 1103.66M |
| FQ1 2025 (Mar 2025) | 10.42 | 10.42 | 1.41768B | 50.41% | 1417.68M |
| FQ4 2024 (Nov 2024) | 4.49 | 4.49 | 0.954671B | 45.19% | 954.67M |
| FQ3 2024 (Aug 2024) | 3.08 | 3.08 | 0.785871B | 41.55% | 785.87M |
| FQ2 2024 (Jun 2024) | 2.32 | 2.32 | 0.640789B | -7.47% | 640.79M |
| FQ1 2024 (Mar 2024) | 3.01 | 3.01 | 0.703076B | -41.88% | 703.08M |
FQ4 Announce Date
02/28/2026 (Pre-Market)
Consensus EPS Estimates
3.03
Consensus Revenue Estimates
0.705775B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.86 | -- | 0.78585 | 0.95061 | 1 |
| FQ1 2027 (Feb 2027) | 2.54 | -- | 2.48706 | 2.57394 | 1 |
| FQ4 2026 (Nov 2026) | 1.02 | -109.8 | 0.93205 | 1.12746 | 1 |
| FQ3 2026 (Aug 2026) | 0.64 | -545.31 | 0.58482 | 0.70743 | 1 |
| FQ2 2026 (May 2026) | 0.735 | -859.18 | 0.68477 | 0.78523 | 1 |
| FQ1 2026 (Feb 2026) | 3.03 | -243.89 | 3.03 | 3.03 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (May 2027) | 0.67B | -- | 0.62B | 0.72B | 1 |
| FQ1 2027 (Feb 2027) | 0.9B | -- | 0.89B | 0.91B | 2 |
| FQ4 2026 (Nov 2026) | 0.7B | -9.63 | 0.66B | 0.76B | 2 |
| FQ3 2026 (Aug 2026) | 0.67B | -38.38 | 0.62B | 0.72B | 2 |
| FQ2 2026 (May 2026) | 0.54B | -104.55 | 0.51B | 0.57B | 1 |
| FQ1 2026 (Feb 2026) | 0.71B | -100.87 | 0.71B | 0.71B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.82 | 2.14 | 0.32 | 14.95% |
| FQ3 2025 (Aug 2025) | 4.13 | 4.13 | 100% | |
| FQ2 2025 (May 2025) | 7.05 | 7.05 | 100% | |
| FQ1 2025 (Mar 2025) | 10.42 | 10.42 | 100% | |
| FQ4 2024 (Nov 2024) | 4.49 | 4.49 | 100% | |
| FQ3 2024 (Aug 2024) | 3.08 | 3.08 | 100% | |
| FQ2 2024 (Jun 2024) | 2.32 | 2.32 | 100% | |
| FQ1 2024 (Mar 2024) | 3.01 | 3.01 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0.54B | $0.77B | $232.17M | 30.17% |
| FQ3 2025 (Aug 2025) | $0B | $0.92B | $922.6M | 100% |
| FQ2 2025 (May 2025) | $0B | $1.1B | $1103.66M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.42B | $1417.68M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.95B | $954.67M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $0.79B | $785.87M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.64B | $640.79M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.7B | $703.08M | 100% |